SlideShare ist ein Scribd-Unternehmen logo
1 von 22
IMMUNOLOGIC
DEFICIENCY SYNDROMES
Divided into:

 Primary immunodeficiency disorders:
  are almost always genetically determined.

 Secondary immunodeficiency states:
 may arise as complications of :- infections; malnutrition;
 aging; or side effects of immunosuppression, irradiation,
 or chemotherapy.
primary immunodeficiency disorders:
 X-Linked Agammaglobulinemia of Bruton:
 characterized by failure of B-cell precursors
  ( pro-B cells and pre-B cells) to mature into B cells.
 is due to mutations in a cytoplasmic tyrosine
  kinase, called B-cell tyrosine kinase (Btk).
 The BTK gene is found on long arm of X chromosome
  ( Xq21.22).
 As X-linked disease, this disorder is seen almost entirely
  in males.
 The disease become apparent about age of 6 months.
 there is recurrent bacterial infections of respiratory
  tract.
 Because antibodies are important for neutralizing
  viruses as well, these patients are also susceptible
  to certain viral infections.
 For similar reasons, Giardia lamblia, an intestinal
  protozoon , that is normally resisted by secreted
  IgA, causes persistent infections in these patients.
 The classic form of this disease has the following
  characteristics :
o B cells are absent or markedly decreased in circulation.
o serum levels of all classes of immunoglobulins are
  depressed.
o Germinal centers of lymph nodes, Peyer
  patches, appendix, and tonsils are underdeveloped or
  rudimentary.
o Plasma cells are absent throughout the body.
o T cell-mediated reactions are entirely normal.
 The treatment of X-linked agammaglobulinemia
  is replacement therapy with immunoglobulins.
Common Variable Immunodeficiency :
 Heterogeneous group of disorders.
 The feature common to all patients is
  hypogammaglobulinemia affecting all antibody classes
  but sometimes only IgG.
 The diagnosis is based on exclusion of other causes
  of decreased antibody production.
 As expected in a heterogeneous group of
  disorders, both sporadic and inherited forms of disease
  occur.
 In inherited forms, there is no single pattern of
  inheritance.
 In contrast to X-linked agammaglobulinemia
  ,       most patients have normal numbers of mature B
  cells in blood and lymphoid tissues.
 These B cells, however, are not able to differentiate
  into plasma cells, so plasma cells are absent.
 There are defects in ability of T cells (TH2 ) to send
  activation signals to B cells.
 According to others, some patients have intrinsic
  B-cell defects , as well as abnormalities of
  T cell-mediated regulation of B cells.
 The clinical manifestations are caused by antibody
  deficiency, and hence resemble those of X-linked
  agammaglobulinemia.
 affects both sexes equally, and the onset of symptoms
  is later in childhood or adolescence.
 Histologically the B-cell areas of lymphoid tissues
  (lymphoid follicles in nodes, spleen, and gut) are
  hyperplastic.
Isolated IgA Deficiency:
 extremely low levels of both serum and secretory IgA.
 It may be familial ( Inherited ); or acquired in
   association with toxoplasmosis, measles, or other
   viral infections.
 Because IgA is major immunoglobulin in external
   secretions, mucosal defenses are weakened, and
   infections occur in respiratory, gastrointestinal, and
   urogenital tracts.
 The basic defect is in differentiation of naive
  (un stimulated ) B lymphocytes to IgA-producing cells.
 Although the molecular basis of this defect is still
  unknown, intrinsic B cell defects or altered T cell help
  (TH2 ) have been implicated.
 In most patients the number of IgA-positive B cells
  is normal, but only a few of these cells can be
  differentiated into IgA plasma cells .
 Serum antibodies to IgA are found in 40% of patients.
Hyper-IgM Syndrome :
 T cell disorder in which functionally abnormal T cells
  ( TH2 ) fail to induce B cells to make antibodies of
  isotypes other than IgM .
 When Naive (unstimulated) B cells stimulated by
  antigens, IgM and IgD antibodies are produced
  first, this is followed by sequential formation of
  IgG, IgA, and IgE antibodies.
 This normal immune response is called isotype
  switching.
 The ability of IgM producing B cells to turn on depends
  on interaction between CD40 molecules on B cells and
  CD40L expressed on T cells.
 In approximately 70% of cases, the mutations
  affect the gene for CD40L, which maps to Xq26.
 These patients have X-linked form of disease.
 In the remaining patients, the mutations affect
  CD40 , or an enzyme called activation-induced
  deaminase which is required for isotype
  switching .
 The disease in these latter groups of patients is
  inherited in autosomal recessive pattern.
 Clinically, patients present with recurrent
  pyogenic infections because the level of IgG
  is low.
 They are also susceptible to pneumonia caused
  by intracellular organism Pneumocystis
  carinii, because of defect in cell-mediated
  immunity.
 The serum contains normal or elevated levels
  of IgM, but no IgA or IgE , and extremely low
  levels of IgG.
 The number of B and T cells is normal.
DiGeorge Syndrome (Thymic Hypoplasia) :
 Results from failure of development of third
  and fourth pharyngeal pouches that give rise to
  thymus , parathyroids , and portions of face
  and aortic arch.
 Thus, these patients have a variable loss of
  T cell-mediated immunity (owing to hypoplasia
  or lack of thymus) ; tetany (owing to lack of
  parathyroids) ; and congenital defects of heart
  and great vessels.
 Absence of cell-mediated immunity is reflected
  in poor defense against certain viral
  , fungal, and protozoal infections.
 Patients are also susceptible to intracellular
  bacteria.
 Immunoglobulin levels may be normal or
  reduced, depending on severity of T-cell
  deficiency.
 In 90% of cases of DiGeorge Syndrome there is
  deletion affecting chromosome 22q 11.
Severe Combined Immunodeficiency Diseases:
 Defects in both humoral and cell-mediated immune
  responses.
 Patients with SCID are extremely susceptible to
  recurrent, severe infections by a wide range of
  pathogens, including Candida albicans, P.
  carinii, Pseudomonas, cytomegalovirus, and bacteria.
 Without bone marrow transplantation, death occurs
  within the first year of life.
 The most common form( 50% to 60% of cases) is
  X-linked, and hence SCID is more common in boys
  than in girls.
 The remaining cases of SCID are inherited as
  autosomal recessives with deficiency of enzyme
  adenosine deaminase (ADA).
 These Mutations prevent development of
  CD4+ T cells.
 CD4+ T cells are involved in cellular immunity and
  provide help to B cells, and hence results in combined
  immunodeficiency.
Immunodeficiency with Thrombocytopenia and Eczema
(Wiskott-Aldrich Syndrome):
 It is X-linked recessive disease ( Xp11.23 ) ,
  characterized by thrombocytopenia, eczema, and
  recurrent infections, ending in early death.
 The thymus is morphologically normal, but there is
  progressive secondary depletion of T lymphocytes in
  peripheral blood and in T-cell zones (paracortical areas)
  of lymph nodes, with variable loss of cellular immunity.
 The only treatment is bone marrow transplantation.
Genetic Deficiencies of Complement System:
 complement system play a critical role in both
  inflammatory and immunologic responses.
 Hereditary deficiencies described for all
  components of complement system and for
  inhibitors.
 Hereditary deficiency of C3 :
    result in increased susceptibility to infection
    with pyogenic bacteria.
 Inherited deficiencies of C1, C2 ,and C4 :
  increase the risk of immune complex- mediated
  diseases ( e.g, SLE ), possibly by impairing
  the clearance of Ag-Ab complexes from
  the circulation.

 Lack of C1 esterase inhibitor:
   allow C1 esterase activation with generation of
   vasoactive mediators that result in hereditory
   angioedema.
 Deficiencies of ( C5 to C9 ) :
  The terminal components of complement
  [ C5, 6, 7, 8, and 9 ] are required for
  membrane attack complex , which involved
  in lysis of organisms ,result in recurrent
  neisserial ( gonococcal and meningococcal )
  infections.
THANK YOU

Weitere ähnliche Inhalte

Was ist angesagt?

Immunodeficiency disease by Dr. Rakesh Prasad Sah
Immunodeficiency disease by Dr. Rakesh Prasad SahImmunodeficiency disease by Dr. Rakesh Prasad Sah
Immunodeficiency disease by Dr. Rakesh Prasad SahDr. Rakesh Prasad Sah
 
Primary immunodeficiency diseases by dr.gobinda
Primary immunodeficiency diseases by dr.gobindaPrimary immunodeficiency diseases by dr.gobinda
Primary immunodeficiency diseases by dr.gobindaGOBINDA PRASAD PRADHAN
 
Severe combined immunodeficiency
Severe combined immunodeficiencySevere combined immunodeficiency
Severe combined immunodeficiencySubash Sapkota
 
Immunological tolerance
Immunological toleranceImmunological tolerance
Immunological toleranceAyesha Zafar
 
severe combined immunodeficiency syndrome
severe combined immunodeficiency syndromesevere combined immunodeficiency syndrome
severe combined immunodeficiency syndromeFatima Sayeed
 
Immunodeficiency Syndrome
Immunodeficiency SyndromeImmunodeficiency Syndrome
Immunodeficiency SyndromeHadi Munib
 
Immunodeficiency (1)
Immunodeficiency (1)Immunodeficiency (1)
Immunodeficiency (1)Sher Khan
 
Primary immunodeficiency
Primary immunodeficiencyPrimary immunodeficiency
Primary immunodeficiencyNishitha Ashok
 
Somatic hypermutation and affinity maturation
Somatic hypermutation and affinity maturationSomatic hypermutation and affinity maturation
Somatic hypermutation and affinity maturationMiriya Johnson
 
Primary Immunodeficiency Disorders
Primary Immunodeficiency DisordersPrimary Immunodeficiency Disorders
Primary Immunodeficiency DisordersMona Mofti
 
severe-combined-immunodeficiency
 severe-combined-immunodeficiency severe-combined-immunodeficiency
severe-combined-immunodeficiencySubhadeep Aditya
 
Immunodeficiency diseases
Immunodeficiency diseasesImmunodeficiency diseases
Immunodeficiency diseasesRAJESH KUMAR
 
Pharm immuno12 &13 tolerance & autoimmunity
Pharm immuno12 &13 tolerance & autoimmunityPharm immuno12 &13 tolerance & autoimmunity
Pharm immuno12 &13 tolerance & autoimmunitymmoney1
 
14 Primary Immunodeficiency Diseases
14 Primary Immunodeficiency  Diseases14 Primary Immunodeficiency  Diseases
14 Primary Immunodeficiency Diseasesghalan
 

Was ist angesagt? (20)

Immunodeficiency disease by Dr. Rakesh Prasad Sah
Immunodeficiency disease by Dr. Rakesh Prasad SahImmunodeficiency disease by Dr. Rakesh Prasad Sah
Immunodeficiency disease by Dr. Rakesh Prasad Sah
 
Immunodeficiency .
Immunodeficiency .   Immunodeficiency .
Immunodeficiency .
 
Primary immunodeficiency diseases by dr.gobinda
Primary immunodeficiency diseases by dr.gobindaPrimary immunodeficiency diseases by dr.gobinda
Primary immunodeficiency diseases by dr.gobinda
 
Severe combined immunodeficiency
Severe combined immunodeficiencySevere combined immunodeficiency
Severe combined immunodeficiency
 
Immunological tolerance
Immunological toleranceImmunological tolerance
Immunological tolerance
 
Secondary immunodeficiency
Secondary immunodeficiencySecondary immunodeficiency
Secondary immunodeficiency
 
severe combined immunodeficiency syndrome
severe combined immunodeficiency syndromesevere combined immunodeficiency syndrome
severe combined immunodeficiency syndrome
 
Immunodeficiency Syndrome
Immunodeficiency SyndromeImmunodeficiency Syndrome
Immunodeficiency Syndrome
 
Immunodeficiency (1)
Immunodeficiency (1)Immunodeficiency (1)
Immunodeficiency (1)
 
Severe combined immunodeficiency - SCID
Severe combined immunodeficiency - SCIDSevere combined immunodeficiency - SCID
Severe combined immunodeficiency - SCID
 
Primary immunodeficiency
Primary immunodeficiencyPrimary immunodeficiency
Primary immunodeficiency
 
Somatic hypermutation and affinity maturation
Somatic hypermutation and affinity maturationSomatic hypermutation and affinity maturation
Somatic hypermutation and affinity maturation
 
Primary Immunodeficiency Disorders
Primary Immunodeficiency DisordersPrimary Immunodeficiency Disorders
Primary Immunodeficiency Disorders
 
Primary immunodeficiency disorders
Primary immunodeficiency disordersPrimary immunodeficiency disorders
Primary immunodeficiency disorders
 
severe-combined-immunodeficiency
 severe-combined-immunodeficiency severe-combined-immunodeficiency
severe-combined-immunodeficiency
 
Immunodeficiency diseases
Immunodeficiency diseasesImmunodeficiency diseases
Immunodeficiency diseases
 
Immunodeficiency
ImmunodeficiencyImmunodeficiency
Immunodeficiency
 
Primary immunodeficiencies
Primary immunodeficienciesPrimary immunodeficiencies
Primary immunodeficiencies
 
Pharm immuno12 &13 tolerance & autoimmunity
Pharm immuno12 &13 tolerance & autoimmunityPharm immuno12 &13 tolerance & autoimmunity
Pharm immuno12 &13 tolerance & autoimmunity
 
14 Primary Immunodeficiency Diseases
14 Primary Immunodeficiency  Diseases14 Primary Immunodeficiency  Diseases
14 Primary Immunodeficiency Diseases
 

Ähnlich wie Immunopathology 4

immunodeficiency for mbbs students to ace in pathology
immunodeficiency for mbbs students to ace in pathologyimmunodeficiency for mbbs students to ace in pathology
immunodeficiency for mbbs students to ace in pathologymakesharumugam23
 
Immunodeficiency diseases.pdf
Immunodeficiency diseases.pdfImmunodeficiency diseases.pdf
Immunodeficiency diseases.pdfSreehariAP1
 
immunodeficiency1-181026134939.pdf
immunodeficiency1-181026134939.pdfimmunodeficiency1-181026134939.pdf
immunodeficiency1-181026134939.pdfSyedMuhammadZakria
 
Immunodeficiency_DISORDERS.pptx.........
Immunodeficiency_DISORDERS.pptx.........Immunodeficiency_DISORDERS.pptx.........
Immunodeficiency_DISORDERS.pptx.........samwel18
 
immunodef dis.pptx
immunodef dis.pptximmunodef dis.pptx
immunodef dis.pptxChinmoy Sahu
 
Immunology-Primary immunodeficiency disorders
Immunology-Primary immunodeficiency disordersImmunology-Primary immunodeficiency disorders
Immunology-Primary immunodeficiency disordersMaryam Al-Maqrashi
 
486 immunoogic disorders
486 immunoogic disorders486 immunoogic disorders
486 immunoogic disordersNabin Chaudhary
 
primary defect in antibody production.pptx
primary defect in antibody production.pptxprimary defect in antibody production.pptx
primary defect in antibody production.pptxIraKC
 
IMMUNODEFICIENCY IN HAEMATOLOGY
IMMUNODEFICIENCY IN HAEMATOLOGYIMMUNODEFICIENCY IN HAEMATOLOGY
IMMUNODEFICIENCY IN HAEMATOLOGYEbiweni Lokoja
 
IMMUNODEFICIENCY DISEASES
IMMUNODEFICIENCY DISEASESIMMUNODEFICIENCY DISEASES
IMMUNODEFICIENCY DISEASESVEENA P KUMAR
 
Congenital and Acquired Immunodeficiency
Congenital and Acquired ImmunodeficiencyCongenital and Acquired Immunodeficiency
Congenital and Acquired ImmunodeficiencyGifteeJRoumi
 
Diagnostic approach to primary immunodefidiency disorder
Diagnostic approach to primary immunodefidiency disorderDiagnostic approach to primary immunodefidiency disorder
Diagnostic approach to primary immunodefidiency disorderPrernaChoudhary15
 
Diseases of the Immune System
Diseases of the Immune SystemDiseases of the Immune System
Diseases of the Immune SystemGhie Santos
 
A S S I N G M E N T
A S S I N G M E N TA S S I N G M E N T
A S S I N G M E N TZahoor Ahmed
 
G.2014-immuno~ (15.immunodeficiency diseases-xm)
 G.2014-immuno~ (15.immunodeficiency diseases-xm) G.2014-immuno~ (15.immunodeficiency diseases-xm)
G.2014-immuno~ (15.immunodeficiency diseases-xm)Helder Jorge Semedo Pires
 

Ähnlich wie Immunopathology 4 (20)

immunodeficiency for mbbs students to ace in pathology
immunodeficiency for mbbs students to ace in pathologyimmunodeficiency for mbbs students to ace in pathology
immunodeficiency for mbbs students to ace in pathology
 
Immunodeficiency diseases.pdf
Immunodeficiency diseases.pdfImmunodeficiency diseases.pdf
Immunodeficiency diseases.pdf
 
immunodeficiency1-181026134939.pdf
immunodeficiency1-181026134939.pdfimmunodeficiency1-181026134939.pdf
immunodeficiency1-181026134939.pdf
 
Ch16 (3)
Ch16 (3)Ch16 (3)
Ch16 (3)
 
ranjithakm-180315143057.pdf
ranjithakm-180315143057.pdfranjithakm-180315143057.pdf
ranjithakm-180315143057.pdf
 
Immunodeficiency_DISORDERS.pptx.........
Immunodeficiency_DISORDERS.pptx.........Immunodeficiency_DISORDERS.pptx.........
Immunodeficiency_DISORDERS.pptx.........
 
immunodef dis.pptx
immunodef dis.pptximmunodef dis.pptx
immunodef dis.pptx
 
Immunology-Primary immunodeficiency disorders
Immunology-Primary immunodeficiency disordersImmunology-Primary immunodeficiency disorders
Immunology-Primary immunodeficiency disorders
 
486 immunoogic disorders
486 immunoogic disorders486 immunoogic disorders
486 immunoogic disorders
 
primary defect in antibody production.pptx
primary defect in antibody production.pptxprimary defect in antibody production.pptx
primary defect in antibody production.pptx
 
IMMUNODEFICIENCY IN HAEMATOLOGY
IMMUNODEFICIENCY IN HAEMATOLOGYIMMUNODEFICIENCY IN HAEMATOLOGY
IMMUNODEFICIENCY IN HAEMATOLOGY
 
Immunodeficiency diseases
Immunodeficiency diseasesImmunodeficiency diseases
Immunodeficiency diseases
 
Hyper Ig M syndrome
Hyper Ig M syndromeHyper Ig M syndrome
Hyper Ig M syndrome
 
IMMUNODEFICIENCY DISEASES
IMMUNODEFICIENCY DISEASESIMMUNODEFICIENCY DISEASES
IMMUNODEFICIENCY DISEASES
 
Congenital and Acquired Immunodeficiency
Congenital and Acquired ImmunodeficiencyCongenital and Acquired Immunodeficiency
Congenital and Acquired Immunodeficiency
 
Diagnostic approach to primary immunodefidiency disorder
Diagnostic approach to primary immunodefidiency disorderDiagnostic approach to primary immunodefidiency disorder
Diagnostic approach to primary immunodefidiency disorder
 
Immunodeficiencies
ImmunodeficienciesImmunodeficiencies
Immunodeficiencies
 
Diseases of the Immune System
Diseases of the Immune SystemDiseases of the Immune System
Diseases of the Immune System
 
A S S I N G M E N T
A S S I N G M E N TA S S I N G M E N T
A S S I N G M E N T
 
G.2014-immuno~ (15.immunodeficiency diseases-xm)
 G.2014-immuno~ (15.immunodeficiency diseases-xm) G.2014-immuno~ (15.immunodeficiency diseases-xm)
G.2014-immuno~ (15.immunodeficiency diseases-xm)
 

Mehr von Forensic Pathology (20)

Stat3 central tendency & dispersion
Stat3 central tendency & dispersionStat3 central tendency & dispersion
Stat3 central tendency & dispersion
 
Exercise 1 12 no solution
Exercise 1 12 no solutionExercise 1 12 no solution
Exercise 1 12 no solution
 
Writing a research protocol 2011
Writing a research protocol 2011Writing a research protocol 2011
Writing a research protocol 2011
 
Some statistical defenition
Some statistical defenitionSome statistical defenition
Some statistical defenition
 
Prac excises 3[1].5
Prac excises 3[1].5Prac excises 3[1].5
Prac excises 3[1].5
 
Exercise 1 12 no solution
Exercise 1 12 no solutionExercise 1 12 no solution
Exercise 1 12 no solution
 
Analysis of variance
Analysis of varianceAnalysis of variance
Analysis of variance
 
Stat6 chi square test
Stat6 chi square testStat6 chi square test
Stat6 chi square test
 
Stat5 the t test
Stat5 the t testStat5 the t test
Stat5 the t test
 
Stat3 central tendency & dispersion
Stat3 central tendency & dispersionStat3 central tendency & dispersion
Stat3 central tendency & dispersion
 
Stat 4 the normal distribution & steps of testing hypothesis
Stat 4 the normal distribution & steps of testing hypothesisStat 4 the normal distribution & steps of testing hypothesis
Stat 4 the normal distribution & steps of testing hypothesis
 
Stat 2 data presentation2
Stat 2 data presentation2Stat 2 data presentation2
Stat 2 data presentation2
 
Correlation 3rd
Correlation 3rdCorrelation 3rd
Correlation 3rd
 
Stat 1 variables & sampling
Stat 1 variables & samplingStat 1 variables & sampling
Stat 1 variables & sampling
 
Pancreas 2
Pancreas 2Pancreas 2
Pancreas 2
 
Pancreas 1
Pancreas 1Pancreas 1
Pancreas 1
 
Liver 3
Liver 3Liver 3
Liver 3
 
Liver 2
Liver 2Liver 2
Liver 2
 
Liver 1
Liver 1Liver 1
Liver 1
 
The biliary tract
The biliary tractThe biliary tract
The biliary tract
 

Immunopathology 4

  • 2. Divided into:  Primary immunodeficiency disorders: are almost always genetically determined.  Secondary immunodeficiency states: may arise as complications of :- infections; malnutrition; aging; or side effects of immunosuppression, irradiation, or chemotherapy.
  • 3. primary immunodeficiency disorders: X-Linked Agammaglobulinemia of Bruton:  characterized by failure of B-cell precursors ( pro-B cells and pre-B cells) to mature into B cells.  is due to mutations in a cytoplasmic tyrosine kinase, called B-cell tyrosine kinase (Btk).  The BTK gene is found on long arm of X chromosome ( Xq21.22).  As X-linked disease, this disorder is seen almost entirely in males.
  • 4.  The disease become apparent about age of 6 months.  there is recurrent bacterial infections of respiratory tract.  Because antibodies are important for neutralizing viruses as well, these patients are also susceptible to certain viral infections.  For similar reasons, Giardia lamblia, an intestinal protozoon , that is normally resisted by secreted IgA, causes persistent infections in these patients.
  • 5.  The classic form of this disease has the following characteristics : o B cells are absent or markedly decreased in circulation. o serum levels of all classes of immunoglobulins are depressed. o Germinal centers of lymph nodes, Peyer patches, appendix, and tonsils are underdeveloped or rudimentary. o Plasma cells are absent throughout the body. o T cell-mediated reactions are entirely normal.  The treatment of X-linked agammaglobulinemia is replacement therapy with immunoglobulins.
  • 6. Common Variable Immunodeficiency :  Heterogeneous group of disorders.  The feature common to all patients is hypogammaglobulinemia affecting all antibody classes but sometimes only IgG.  The diagnosis is based on exclusion of other causes of decreased antibody production.  As expected in a heterogeneous group of disorders, both sporadic and inherited forms of disease occur.  In inherited forms, there is no single pattern of inheritance.
  • 7.  In contrast to X-linked agammaglobulinemia , most patients have normal numbers of mature B cells in blood and lymphoid tissues.  These B cells, however, are not able to differentiate into plasma cells, so plasma cells are absent.  There are defects in ability of T cells (TH2 ) to send activation signals to B cells.  According to others, some patients have intrinsic B-cell defects , as well as abnormalities of T cell-mediated regulation of B cells.
  • 8.  The clinical manifestations are caused by antibody deficiency, and hence resemble those of X-linked agammaglobulinemia.  affects both sexes equally, and the onset of symptoms is later in childhood or adolescence.  Histologically the B-cell areas of lymphoid tissues (lymphoid follicles in nodes, spleen, and gut) are hyperplastic.
  • 9. Isolated IgA Deficiency:  extremely low levels of both serum and secretory IgA.  It may be familial ( Inherited ); or acquired in association with toxoplasmosis, measles, or other viral infections.  Because IgA is major immunoglobulin in external secretions, mucosal defenses are weakened, and infections occur in respiratory, gastrointestinal, and urogenital tracts.
  • 10.  The basic defect is in differentiation of naive (un stimulated ) B lymphocytes to IgA-producing cells.  Although the molecular basis of this defect is still unknown, intrinsic B cell defects or altered T cell help (TH2 ) have been implicated.  In most patients the number of IgA-positive B cells is normal, but only a few of these cells can be differentiated into IgA plasma cells .  Serum antibodies to IgA are found in 40% of patients.
  • 11. Hyper-IgM Syndrome :  T cell disorder in which functionally abnormal T cells ( TH2 ) fail to induce B cells to make antibodies of isotypes other than IgM .  When Naive (unstimulated) B cells stimulated by antigens, IgM and IgD antibodies are produced first, this is followed by sequential formation of IgG, IgA, and IgE antibodies.  This normal immune response is called isotype switching.  The ability of IgM producing B cells to turn on depends on interaction between CD40 molecules on B cells and CD40L expressed on T cells.
  • 12.  In approximately 70% of cases, the mutations affect the gene for CD40L, which maps to Xq26.  These patients have X-linked form of disease.  In the remaining patients, the mutations affect CD40 , or an enzyme called activation-induced deaminase which is required for isotype switching .  The disease in these latter groups of patients is inherited in autosomal recessive pattern.
  • 13.  Clinically, patients present with recurrent pyogenic infections because the level of IgG is low.  They are also susceptible to pneumonia caused by intracellular organism Pneumocystis carinii, because of defect in cell-mediated immunity.  The serum contains normal or elevated levels of IgM, but no IgA or IgE , and extremely low levels of IgG.  The number of B and T cells is normal.
  • 14. DiGeorge Syndrome (Thymic Hypoplasia) :  Results from failure of development of third and fourth pharyngeal pouches that give rise to thymus , parathyroids , and portions of face and aortic arch.  Thus, these patients have a variable loss of T cell-mediated immunity (owing to hypoplasia or lack of thymus) ; tetany (owing to lack of parathyroids) ; and congenital defects of heart and great vessels.
  • 15.  Absence of cell-mediated immunity is reflected in poor defense against certain viral , fungal, and protozoal infections.  Patients are also susceptible to intracellular bacteria.  Immunoglobulin levels may be normal or reduced, depending on severity of T-cell deficiency.  In 90% of cases of DiGeorge Syndrome there is deletion affecting chromosome 22q 11.
  • 16. Severe Combined Immunodeficiency Diseases:  Defects in both humoral and cell-mediated immune responses.  Patients with SCID are extremely susceptible to recurrent, severe infections by a wide range of pathogens, including Candida albicans, P. carinii, Pseudomonas, cytomegalovirus, and bacteria.  Without bone marrow transplantation, death occurs within the first year of life.  The most common form( 50% to 60% of cases) is X-linked, and hence SCID is more common in boys than in girls.
  • 17.  The remaining cases of SCID are inherited as autosomal recessives with deficiency of enzyme adenosine deaminase (ADA).  These Mutations prevent development of CD4+ T cells.  CD4+ T cells are involved in cellular immunity and provide help to B cells, and hence results in combined immunodeficiency.
  • 18. Immunodeficiency with Thrombocytopenia and Eczema (Wiskott-Aldrich Syndrome):  It is X-linked recessive disease ( Xp11.23 ) , characterized by thrombocytopenia, eczema, and recurrent infections, ending in early death.  The thymus is morphologically normal, but there is progressive secondary depletion of T lymphocytes in peripheral blood and in T-cell zones (paracortical areas) of lymph nodes, with variable loss of cellular immunity.  The only treatment is bone marrow transplantation.
  • 19. Genetic Deficiencies of Complement System:  complement system play a critical role in both inflammatory and immunologic responses.  Hereditary deficiencies described for all components of complement system and for inhibitors.  Hereditary deficiency of C3 : result in increased susceptibility to infection with pyogenic bacteria.
  • 20.  Inherited deficiencies of C1, C2 ,and C4 : increase the risk of immune complex- mediated diseases ( e.g, SLE ), possibly by impairing the clearance of Ag-Ab complexes from the circulation.  Lack of C1 esterase inhibitor: allow C1 esterase activation with generation of vasoactive mediators that result in hereditory angioedema.
  • 21.  Deficiencies of ( C5 to C9 ) : The terminal components of complement [ C5, 6, 7, 8, and 9 ] are required for membrane attack complex , which involved in lysis of organisms ,result in recurrent neisserial ( gonococcal and meningococcal ) infections.